Waters Co. (NYSE:WAT) SVP Terrence P. Kelly sold 1,312 shares of the stock in a transaction that occurred on Friday, March 9th. The stock was sold at an average price of $212.52, for a total value of $278,826.24. Following the completion of the transaction, the senior vice president now directly owns 5,130 shares of the company’s stock, valued at $1,090,227.60. The sale was disclosed in a filing with the SEC, which is available at this link.
Shares of Waters Co. (WAT) opened at $212.87 on Tuesday. The company has a market capitalization of $16,910.00, a P/E ratio of 29.94, a P/E/G ratio of 2.55 and a beta of 0.90. Waters Co. has a 12-month low of $153.04 and a 12-month high of $220.20. The company has a current ratio of 7.04, a quick ratio of 6.60 and a debt-to-equity ratio of 0.85.
Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 EPS for the quarter, topping the Zacks’ consensus estimate of $2.44 by $0.07. The business had revenue of $687.28 million for the quarter, compared to analyst estimates of $671.98 million. Waters had a return on equity of 24.70% and a net margin of 0.88%. Waters’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the prior year, the company earned $2.21 EPS. analysts anticipate that Waters Co. will post 8.16 earnings per share for the current year.
A number of brokerages have recently issued reports on WAT. BTIG Research reissued a “buy” rating on shares of Waters in a report on Thursday, January 25th. Robert W. Baird increased their target price on Waters from $219.00 to $220.00 and gave the stock an “outperform” rating in a report on Wednesday, January 24th. JPMorgan Chase & Co. increased their target price on Waters from $180.00 to $200.00 and gave the stock a “neutral” rating in a report on Wednesday, January 24th. Citigroup increased their target price on Waters from $190.00 to $223.00 and gave the stock a “neutral” rating in a report on Wednesday, January 24th. Finally, Barclays increased their target price on Waters from $202.00 to $208.00 and gave the stock an “equal weight” rating in a report on Wednesday, January 24th. Thirteen investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $203.75.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Banco de Sabadell S.A bought a new stake in Waters during the 4th quarter worth approximately $193,000. Brown Advisory Securities LLC bought a new stake in Waters during the 4th quarter worth approximately $202,000. Checchi Capital Advisers LLC bought a new stake in Waters during the 4th quarter worth approximately $210,000. Trust Co. of Virginia VA bought a new position in Waters in the 4th quarter valued at $213,000. Finally, Zions Bancorporation boosted its position in Waters by 12,075.0% in the 3rd quarter. Zions Bancorporation now owns 1,461 shares of the medical instruments supplier’s stock valued at $262,000 after buying an additional 1,449 shares during the last quarter. Institutional investors and hedge funds own 94.96% of the company’s stock.
WARNING: This piece was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/03/13/waters-co-wat-svp-sells-278826-24-in-stock.html.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.